Cara Cassino
Company: ContraFect
Job title: Executive Vice President of R&D & Chief Medical Officer
Seminars:
Q&A/Discussion 9:50 am
day: Day Two
Direct Lytic Agents (DLA): New Medical Modalities for Life- Threatening, Drug-Resistant Infections 9:00 am
Harnessing the antimicrobial power of DLAs Translating the power of DLAs to clinical development Demonstrating the potential for superior outcomes for serious, life threatening, critically underserved infectionsRead more
day: Day Two